899 related articles for article (PubMed ID: 29246151)
1. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
Boytsov S; Logunova N; Khomitskaya Y;
Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
[TBL] [Abstract][Full Text] [Related]
2. Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey.
Park JE; Chiang CE; Munawar M; Pham GK; Sukonthasarn A; Aquino AR; Khoo KL; Chan HW
Eur J Prev Cardiol; 2012 Aug; 19(4):781-94. PubMed ID: 21450606
[TBL] [Abstract][Full Text] [Related]
3. Gender and ethnic differences in the control of hyperlipidaemia and other vascular risk factors: insights from the CEntralised Pan-South African survey on tHE Under-treatment of hypercholeSterolaemia (CEPHEUS SA) study.
Rapeport N; Schamroth CL; Blom DJ
Cardiovasc J Afr; 2013 Jul; 24(6):238-42. PubMed ID: 24217264
[TBL] [Abstract][Full Text] [Related]
4. Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey.
Wang KF; Chang CC; Wang KL; Wu CH; Chen LC; Lu TM; Lin SJ; Chiang CE
J Chin Med Assoc; 2014 Feb; 77(2):61-7. PubMed ID: 24332414
[TBL] [Abstract][Full Text] [Related]
5. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
[TBL] [Abstract][Full Text] [Related]
6. The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS Findings.
Shehab A; Al-Rasadi K; Arafah M; Al-Hinai AT; Al Mahmeed W; Bhagavathula AS; Al Tamimi O; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Alawadhi M; Amin H; Al-Hashmi K; Oulhaj A
Curr Vasc Pharmacol; 2018; 16(4):368-375. PubMed ID: 28677510
[TBL] [Abstract][Full Text] [Related]
7. CEPHEUS SA: a South African survey on the undertreatment of hypercholesterolaemia.
Raal F; Schamroth C; Blom D; Marx J; Rajput M; Haus M; Hussain R; Cassim F; Nortjé M; Vandehoven G; Temmerman AM
Cardiovasc J Afr; 2011; 22(5):234-40. PubMed ID: 21922121
[TBL] [Abstract][Full Text] [Related]
8. Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs--the CEPHEUS-Greece survey.
Elisaf MS; Nikas N
Angiology; 2010 Jul; 61(5):465-74. PubMed ID: 20462896
[TBL] [Abstract][Full Text] [Related]
9. Lipid-lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic.
Kiburg KV; Ward GM; O'Neal DN; MacIsaac RJ
Intern Med J; 2018 Feb; 48(2):201-204. PubMed ID: 29415350
[TBL] [Abstract][Full Text] [Related]
10. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
[TBL] [Abstract][Full Text] [Related]
11. Achieving low-density lipoprotein cholesterol treatment goals among dyslipidemic individuals in the Levant: the CEntralized Pan-Levant survey on tHE Undertreatment of hypercholeSterolemia (CEPHEUS) study.
Hammoudeh AJ; Echtay A; Ghanem GY; Haddad J;
Curr Med Res Opin; 2014 Oct; 30(10):1957-65. PubMed ID: 24889279
[TBL] [Abstract][Full Text] [Related]
12. Lipid attainment among patients newly treated with lipid-altering drugs.
Hess G; Chang CL; Chung K
Curr Med Res Opin; 2014 Sep; 30(9):1743-56. PubMed ID: 24889282
[TBL] [Abstract][Full Text] [Related]
13. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
[TBL] [Abstract][Full Text] [Related]
14. Centralized Pan-European survey on the undertreatment of hypercholesterolaemia (CEPHEUS).
Hermans MP; Van Mieghem W; Vandenhoven G; Vissers E
Acta Cardiol; 2009 Apr; 64(2):177-85. PubMed ID: 19476109
[TBL] [Abstract][Full Text] [Related]
15. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
[TBL] [Abstract][Full Text] [Related]
16. Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS).
Chiang CE; Ferrières J; Gotcheva NN; Raal FJ; Shehab A; Sung J; Henriksson KM; Hermans MP
J Atheroscler Thromb; 2016 May; 23(5):567-87. PubMed ID: 26632163
[TBL] [Abstract][Full Text] [Related]
17. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
[TBL] [Abstract][Full Text] [Related]
18. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS).
Danchin N; Almahmeed W; Al-Rasadi K; Azuri J; Berrah A; Cuneo CA; Karpov Y; Kaul U; Kayıkçıoğlu M; Mitchenko O; Ruiz AJ; Aguilar Salinas CA; Santos RD; Mercier F; Blom D;
Eur J Prev Cardiol; 2018 Jul; 25(10):1087-1094. PubMed ID: 29771156
[TBL] [Abstract][Full Text] [Related]
19. Gaps in Dyslipidemia Care Among Working-Aged Individuals With Employer-Sponsored Health Care.
Shiffman D; Louie JZ; Devlin JJ; Knowles JW; McPhaul MJ
J Am Heart Assoc; 2020 May; 9(9):e015807. PubMed ID: 32319337
[TBL] [Abstract][Full Text] [Related]
20. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
Wens J; Gerard R; Vandenberghe H
Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
